Publications by authors named "Benyao Lin"

Claim this Profile
S
Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in Mutation Carriers.
Li Hu, Liming Su, Hainan Cheng, Chunling Mo, Tao Ouyang, Benyao Lin

Cancer Res· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical phenotypes combined with saturation genome editing identifying the pathogenicity of BRCA1 variants of uncertain significance in breast cancer.
Qiting Wan, Li Hu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

Fam Cancer· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Survival After Breast-Conserving Therapy vs Mastectomy Among Patients With or Without the BRCA1/2 Variant in a Large Series of Unselected Chinese Patients With Breast Cancer.
Qiting Wan, Liming Su, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

JAMA Netw Open· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of the addition of carboplatin to anthracycline-taxane-based neoadjuvant chemotherapy on survival in BRCA1/2-mutated triple-negative breast cancer.
Juan Zhang, Lu Yao, Yiqiang Liu, Tao Ouyang, Jinfeng Li, Benyao Lin

Int J Cancer· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRCA1 c.5470_5477del, a founder mutation in Chinese Han breast cancer patients.
Hua Meng, Lu Yao, Hua Yuan, Ye Xu, Tao Ouyang, Benyao Lin

Int J Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients.
Liming Su, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

Int J Cancer· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum and clinical relevance of PALB2 germline mutations in 7657 Chinese BRCA1/2-negative breast cancer patients.
Yifan Wu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Benyao Lin

Breast Cancer Res Treat· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and clinical impact of TP53 germline mutations in Chinese women with breast cancer.
Shuyan Sheng, Ye Xu, Yonghai Guo, Lu Yao, Li Hu, Benyao Lin

Int J Cancer· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline mutation in DNA-repair genes is associated with poor survival in BRCA1/2-negative breast cancer patients.
Zhenhua Fan, Li Hu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

Cancer Sci· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Co-mutation of TP53 and PIK3CA in residual disease after neoadjuvant chemotherapy is associated with poor survival in breast cancer.
Xinyi Chen, Yonghai Guo, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

J Cancer Res Clin Oncol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Ziguo Yang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Benyao Lin

Breast Cancer Res Treat· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between HER2 germline mutation A270S and prognosis in patients with primary breast cancer.
Pilei Si, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

Cancer Biomark· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAD50 germline mutations are associated with poor survival in BRCA1/2-negative breast cancer patients.
Cong Fan, Juan Zhang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

Int J Cancer· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low expression of RECQL is associated with poor prognosis in Chinese breast cancer patients.
Huiying Xu, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

BMC Cancer· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and analysis of CHEK2 germline mutations in Chinese BRCA1/2-negative breast cancer patients.
Zhenhua Fan, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Benyao Lin

Breast Cancer Res Treat· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive value of BRCA1/2 mRNA expression for response to neoadjuvant chemotherapy in BRCA-negative breast cancers.
Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Benyao Lin

Cancer Sci· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline Mutations in Cancer Susceptibility Genes in a Large Series of Unselected Breast Cancer Patients.
Jie Sun, Hua Meng, Lu Yao, Meng Lv, Jian Bai, Benyao Lin

Clin Cancer Res· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 Pro1170Ala polymorphism is associated with decreased survival rate in HER2-negative breast cancer.
Pilei Si, Ye Xu, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

Oncol Lett· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 somatic mutations are associated with poor survival in HER2-negative breast cancers.
Tonghui Wang, Ye Xu, Shuyan Sheng, Hua Yuan, Tao Ouyang, Benyao Lin

Cancer Sci· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.
Juan Zhang, Jie Sun, Jiuan Chen, Lu Yao, Tao Ouyang, Benyao Lin

Breast Cancer Res Treat· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of BRCA1 somatic mutations and response to neoadjuvant chemotherapy in Chinese women with triple-negative breast cancer.
Manxiu Li, Juan Zhang, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Benyao Lin

Gene· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer risk in Chinese women with BRCA1 or BRCA2 mutations.
Lu Yao, Jie Sun, Juan Zhang, Yingjian He, Tao Ouyang, Benyao Lin

Breast Cancer Res Treat· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A genome-wide association study identifies WT1 variant with better response to 5-fluorouracil, pirarubicin and cyclophosphamide neoadjuvant chemotherapy in breast cancer patients.
Lina Wu, Lu Yao, Hong Zhang, Tao Ouyang, Jinfeng Li, Benyao Lin

Oncotarget· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast-conserving therapy and modified radical mastectomy for primary breast carcinoma: a matched comparative study.
Lize Wang, Tao Ouyang, Tianfeng Wang, Yuntao Xie, Zhaoqing Fan, Benyao Lin

Chin J Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between HER2 status and response to neoadjuvant anthracycline followed by paclitaxel plus carboplatin chemotherapy without trastuzumab in breast cancer.
Lu Yao, Juan Zhang, Yiqiang Liu, Tao Ouyang, Jinfeng Li, Benyao Lin

Chin J Cancer Res· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis